Operating Lease, Right-of-Use Asset of BIOGEN INC. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BIOGEN INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • BIOGEN INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $330,500,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BIOGEN INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $330,500,000 -$49,900,000 -13% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $334,500,000 -$54,900,000 -14% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $346,400,000 -$81,700,000 -19% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $356,400,000 -$63,600,000 -15% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $380,400,000 -$80,500,000 -17% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $389,400,000 +$22,900,000 +6.2% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $428,100,000 +$29,000,000 +7.3% 31 Mar 2024 10-Q 24 Apr 2024 2024 Q1
Q4 2023 $420,000,000 +$16,100,000 +4% 31 Dec 2023 10-K 12 Feb 2025 2024 FY
Q3 2023 $460,900,000 +$36,400,000 +8.6% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $366,500,000 +$45,400,000 +14% 30 Jun 2023 10-Q 25 Jul 2023 2023 Q2
Q1 2023 $399,100,000 +$40,100,000 +11% 31 Mar 2023 10-Q 25 Apr 2023 2023 Q1
Q4 2022 $403,900,000 +$28,500,000 +7.6% 31 Dec 2022 10-K 14 Feb 2024 2023 FY
Q3 2022 $424,500,000 +$35,400,000 +9.1% 30 Sep 2022 10-Q 25 Oct 2022 2022 Q3
Q2 2022 $321,100,000 -$81,400,000 -20% 30 Jun 2022 10-Q 20 Jul 2022 2022 Q1
Q1 2022 $359,000,000 -$55,500,000 -13% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $375,400,000 -$57,900,000 -13% 31 Dec 2021 10-K 15 Feb 2023 2022 FY
Q3 2021 $389,100,000 -$45,100,000 -10% 30 Sep 2021 10-Q 20 Oct 2021 2021 Q3
Q2 2021 $402,500,000 -$33,700,000 -7.7% 30 Jun 2021 10-Q 22 Jul 2021 2021 Q2
Q1 2021 $414,500,000 -$7,500,000 -1.8% 31 Mar 2021 10-Q 22 Apr 2021 2021 Q1
Q4 2020 $433,300,000 +$6,300,000 +1.5% 31 Dec 2020 10-K 03 Feb 2022 2021 FY
Q3 2020 $434,200,000 +$12,200,000 +2.9% 30 Sep 2020 10-Q 21 Oct 2020 2020 Q3
Q2 2020 $436,200,000 +$1,800,000 +0.41% 30 Jun 2020 10-Q 22 Jul 2020 2020 Q2
Q1 2020 $422,000,000 -$25,800,000 -5.8% 31 Mar 2020 10-Q 23 Apr 2020 2020 Q1
Q4 2019 $427,000,000 +$427,000,000 31 Dec 2019 10-K 03 Feb 2021 2020 FY
Q3 2019 $422,000,000 30 Sep 2019 10-Q 22 Oct 2019 2019 Q3
Q2 2019 $434,400,000 30 Jun 2019 10-Q 24 Jul 2019 2019 Q2
Q1 2019 $447,800,000 31 Mar 2019 10-Q 24 Apr 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 06 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.